Mexico Network Point-of-care Glucose Testing Market Size & Outlook
Related Markets
Mexico network point-of-care glucose testing market highlights
- The Mexico network point-of-care glucose testing market generated a revenue of USD 16.7 million in 2023 and is expected to reach USD 20.2 million by 2030.
- The Mexico market is expected to grow at a CAGR of 2.7% from 2024 to 2030.
- In terms of segment, accu-chek inform ii was the largest revenue generating product in 2023.
- CareSens Expert Plus is the most lucrative product segment registering the fastest growth during the forecast period.
Network point-of-care glucose testing market data book summary
| Market revenue in 2023 | USD 16.7 million |
| Market revenue in 2030 | USD 20.2 million |
| Growth rate | 2.7% (CAGR from 2024 to 2030) |
| Largest segment | Accu-chek inform ii |
| Fastest growing segment | CareSens Expert Plus |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | I-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue |
| Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.3% of the global network point-of-care glucose testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil network point-of-care glucose testing market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 27.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Network Point-of-Care Glucose Testing Market Scope
Network Point-of-Care Glucose Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Nova Biomedical | View profile | 501-1000 | Waltham, Massachusetts, United States, North America | http://www.novabio.us |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Mexico network point-of-care glucose testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 52.1% in 2023. Horizon Databook has segmented the Mexico network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2018 to 2030.
The POC testing solutions in Mexican Association of Clinical Laboratory Sciences (CMCLC) are witnessing various improvements in terms of adoption and awareness. Self-monitoring devices and emergency departments have been witnessing greater demand in recent years, which offers lucrative growth opportunities to POC glucose testing product manufacturers in the country.
However, main barriers to market entry include higher cost of POC testing devices, restrictive government policies & their implementation, and higher adoption of sophisticated POC testing devices across intensive care units in comparison with other medical settings.
In spite of increasing adoption of POC devices in emergency units, lack of collaborative authorities that can aid in improving quality of management is expected to hinder the market growth.
Reasons to subscribe to Mexico network point-of-care glucose testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico network point-of-care glucose testing market databook
-
Our clientele includes a mix of network point-of-care glucose testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico network point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico network point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico network point-of-care glucose testing market size, by product, 2018-2030 (US$M)
Mexico Network Point-of-Care Glucose Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
